These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2308979

  • 1. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
    Tong AW, Dalton WS, Tsuruo T, Fay JW, Stone MJ.
    Prog Clin Biol Res; 1990; 333():155-64. PubMed ID: 2308979
    [Abstract] [Full Text] [Related]

  • 2. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
    Tong AW, Lee J, Wang RM, Dalton WS, Tsuruo T, Fay JW, Stone MJ.
    Cancer Res; 1989 Sep 01; 49(17):4829-34. PubMed ID: 2569359
    [Abstract] [Full Text] [Related]

  • 3. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
    Stone MJ, Tong AW, Fay JW, Lee JC.
    Cancer Detect Prev; 1988 Sep 01; 12(1-6):621-35. PubMed ID: 3180147
    [Abstract] [Full Text] [Related]

  • 4. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
    Kulkarni SS, Wang ZM, Spitzer G, Taha M, Hamada H, Tsuruo T, Dicke KA.
    Blood; 1989 Nov 01; 74(6):2244-51. PubMed ID: 2572283
    [Abstract] [Full Text] [Related]

  • 5. Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement.
    Tong AW, Lee JC, Fay JW, Stone MJ.
    Blood; 1987 Nov 01; 70(5):1482-9. PubMed ID: 3663943
    [Abstract] [Full Text] [Related]

  • 6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar 01; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 7. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
    Bast RC, De Fabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz J.
    Cancer Res; 1985 Feb 01; 45(2):499-503. PubMed ID: 3967224
    [Abstract] [Full Text] [Related]

  • 8. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
    Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS.
    Cancer Res; 1996 Dec 01; 56(23):5435-42. PubMed ID: 8968098
    [Abstract] [Full Text] [Related]

  • 9. Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens.
    Futscher BW, Blake LL, Gerlach JH, Grogan TM, Dalton WS.
    Anal Biochem; 1993 Sep 01; 213(2):414-21. PubMed ID: 8238918
    [Abstract] [Full Text] [Related]

  • 10. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
    Hu ZB, Yu ZF, Qiao CN, Ma WL.
    Chin Med J (Engl); 1991 Aug 01; 104(8):664-8. PubMed ID: 1914634
    [Abstract] [Full Text] [Related]

  • 11. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
    Uckun FM, Ramakrishnan S, Houston LL.
    J Immunol; 1985 Mar 01; 134(3):2010-6. PubMed ID: 3855433
    [Abstract] [Full Text] [Related]

  • 12. Preclinical evaluation of immunoconjugates consisting of doxorubicin linked to complement-fixing monoclonal antibody DLC-48 for bone marrow purging of B-cell lymphomas.
    Winter JN, Bass B, Bringman T, Nedwin G.
    Prog Clin Biol Res; 1990 Mar 01; 333():171-83. PubMed ID: 2408059
    [Abstract] [Full Text] [Related]

  • 13. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
    Howell AL, Fogg-Leach M, Davis BH, Ball ED.
    Bone Marrow Transplant; 1989 May 01; 4(3):317-22. PubMed ID: 2659117
    [Abstract] [Full Text] [Related]

  • 14. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging.
    Janssen WE, Lee C, Gross S, Gee AP.
    Exp Hematol; 1989 Mar 01; 17(3):252-7. PubMed ID: 2917623
    [Abstract] [Full Text] [Related]

  • 15. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
    Sao H, Morishima Y, Ueda R, Yoshikawa S, Kodera Y, Ohno R, Takahashi T.
    Jpn J Cancer Res; 1985 Dec 01; 76(12):1212-21. PubMed ID: 3937833
    [Abstract] [Full Text] [Related]

  • 16. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
    Howell AL, Miller R, Keefe KA, McIntyre OR, Stockner M, Sullivan R, Hibbert SR, Noelle RJ, Ball ED.
    Exp Hematol; 1988 Mar 01; 16(3):176-83. PubMed ID: 3422192
    [Abstract] [Full Text] [Related]

  • 17. T-cell depletion of Cercopithecus aethiops monkey bone marrow with Campath-1 monoclonal antibody and complement.
    Phan DT, Barta E, Gidáli J, Fehér I, Harsányi V, Petrányi GG, Hollán SR.
    Haematologia (Budap); 1987 Mar 01; 20(3):155-63. PubMed ID: 3500899
    [Abstract] [Full Text] [Related]

  • 18. Anti-neuroblastoma monoclonal antibodies which do not bind to bone marrow cells.
    Frantz CN, Duerst RE, Ryan DH, Gelsomino NL, Constine LS, Gregory PK.
    Prog Clin Biol Res; 1985 Mar 01; 175():485-99. PubMed ID: 3887430
    [Abstract] [Full Text] [Related]

  • 19. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.
    Tong AW, Huang YW, Zhang BQ, Netto G, Vitetta ES, Stone MJ.
    Anticancer Res; 1993 Mar 01; 13(3):593-7. PubMed ID: 8391243
    [Abstract] [Full Text] [Related]

  • 20. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y, Feyens AM, Sekhavat M, Agaliotis D, Canon JL, Symann ML.
    Cancer Res; 1989 Sep 15; 49(18):5058-61. PubMed ID: 2548708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.